The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.